Company profile:
The company has a registered capital of 299 million yuan, total assets of 654.38+07 billion yuan, an area of over 800,000 square meters and more than 2,800 employees. We have set up 65,438+065,438+0 branches in Linhai, Hangzhou, Shanghai and the United States respectively.
The company's main business is pharmaceutical preparations, raw materials and intermediates, and it has formed a product pattern with obvious characteristics of cardiovascular drugs, antidepressants and antiviral drugs, which are refined and strong, serialized and developed on a large scale. Among them, ACE inhibitors, a cardiovascular drug, have the largest variety, the largest production and sales volume, and the world-leading technical level, enjoying the reputation of "Puli experts".
The company has a sound management system, and all its products have passed the national GMP certification. It is one of the enterprises with the most international drug quality certification in China.